Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04368039
NA
Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
Sponsor: Nicholas Breitborde
View on ClinicalTrials.gov
Summary
Single-blind, randomized controlled trial of normobaric oxygen therapy among individuals with first-episode psychosis: Effects on symptomatology and cognition.
Key Details
Gender
All
Age Range
15 Years - 35 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2019-12-04
Completion Date
2026-12-07
Last Updated
2026-02-25
Healthy Volunteers
No
Interventions
DEVICE
Normobaric Oxygen
40% FiO2 for 4 weeks
DEVICE
Placebo
21% FiO2 for 4 weeks
Locations (1)
Harding Hospital
Columbus, Ohio, United States